Search: id:"swepub:oai:DiVA.org:oru-105786" >
Important considera...
-
Kong, Fabian Yuh ShiongCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia
(author)
Important considerations regarding the widespread use of doxycycline chemoprophylaxis against sexually transmitted infections
- Article/chapterEnglish2023
Publisher, publication year, extent ...
-
Oxford University Press,2023
-
printrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:oru-105786
-
https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-105786URI
-
https://doi.org/10.1093/jac/dkad129DOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:for swepub-publicationtype
Notes
-
Funding agencies:University of Melbourne Faculty C.R. Roper Fellowship Australian Research Council IH190100021
-
Rates of sexually transmitted infections (STIs) continue to rise across the world and interventions are essential to reduce their incidence. Past and recent studies have indicated this may be achieved using doxycycline post-exposure prophylaxis (PEP) and this has sparked considerable interest in its use. However, many unanswered questions remain as to its long-term effects and particularly potentially negative impact on human microbiomes and antimicrobial resistance among STIs, other pathogens, and commensals. In this review, we discuss seven areas of concern pertaining to the widespread use of doxycycline PEP.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Kenyon, ChrisHIV/STI Unit, Institute of Tropical Medicine, Antwerp, Belgium; Division of Infectious Diseases and HIV Medicine, University of Cape Town, Cape Town, South Africa
(author)
-
Unemo, Magnus,1970-Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län,WHO Collaborating Centre for Gonorrhoea and Other STIs, National Reference Laboratory for STIs, Department of Laboratory Medicine, Örebro University, Örebro, Sweden; Faculty of Population Health Sciences, Institute for Global Health, University College London, London, UK(Swepub:oru)muo
(author)
-
Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, AustraliaHIV/STI Unit, Institute of Tropical Medicine, Antwerp, Belgium; Division of Infectious Diseases and HIV Medicine, University of Cape Town, Cape Town, South Africa
(creator_code:org_t)
Related titles
-
In:Journal of Antimicrobial Chemotherapy: Oxford University Press78:7, s. 1561-15680305-74531460-2091
Internet link
Find in a library
To the university's database